Oxford Nanopore sequencing solutions for cell and gene therapies

Overview

Cell and gene therapy development is inherently complex. That is why comprehensive sequencing is essential: it serves as a critical checkpoint at every stage in cell and gene therapy development. However, legacy next-generation sequencing (NGS) methods require fragmentation and amplification steps, erasing critical sample information. Discover how Oxford Nanopore sequencing overcomes these limitations with direct, PCR-free workflows to reveal the true biology of your samples.

In this brochure, find out how nanopore sequencing can be applied in the development of cell, gene, and RNA therapies to provide the data you need to develop better and safer drugs, whilst reducing risk .